Helen Gu

747 citations
19 papers · 507 indexed · h-index 12
Topics
Pharmacogenetics and Drug Metabolism (11 papers)Drug Transport and Resistance Mechanisms (8 papers)Eicosanoids and Hypertension Pharmacology (2 papers)

In The Last Decade

Helen Gu

19 papers receiving 490 citations

Peers

Helen Gu
Comparison fields: 5 of 90
  • Oncology 117
  • Molecular Biology 112
  • Pharmacology 110
  • Pharmacology 109
  • Endocrinology, Diabetes and Metabolism 103
Replace Rianto Setiabudy with:
Rianto Setiabudy Indonesia
François A. Leblond Canada
Kiran Dole United States
Sarah L. Greig New Zealand
Gary D. Bowers United States
Jin Ah Jung South Korea
Danilo Wegner Germany
Vaishali Dixit United States
Jennifer J. Harris United States
Constantin Efthymiopoulos United Kingdom
Helen Gu relative to Rianto Setiabudy Indonesia Rianto Setiabudy's profile →
Citations per field
00.5×1.5×2.3×
Rianto Setiabudy · 1×
Citations per year

Countries citing papers authored by Helen Gu

Since Specialization
Citations

This map shows the geographic impact of Helen Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Gu more than expected).

Fields of papers citing papers by Helen Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Gu. The network helps show where Helen Gu may publish in the future.

Co-authorship network of co-authors of Helen Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Gu. A scholar is included among the top collaborators of Helen Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Gu. Helen Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 2
2 1
3 1
4 3
5 25
6 25
7 6
8 36
9 30
10 30
11 43
12 27
13 11
14 17
15 8
16 54
17 119
18 1
19 68

About Helen Gu

Helen Gu is a scholar working on Pharmacology, Oncology and Biochemistry, having authored 19 papers that have together received 507 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (8 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Pharmacology (109 citations), Pharmacology (110 citations) and Endocrinology, Diabetes and Metabolism (103 citations). Helen Gu has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Heidi J. Einolf, James B. Mangold, Handan He, Lai Wang, Lolita C. Rodriguez, Volker Fischer, Yannick Batard, Hequn Yin, Christiane Rordorf and Dan Howard. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Drug Metabolism and Disposition and European Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026